Company news
Genedrive PLC news in 2026
Genedrive PLC's news releases, calls and decks from 2026, newest first.
NIHR highlights genedrive's rapid genetic test
October 12, 2026
Welsh hospitals extend routine MT-RNR1 testing
September 10, 2026
ShareSoc Investor Presentation Reminder
September 3, 2026
Director/PDMR Notification
September 1, 2026
Board Appointments
August 21, 2026
ShareSoc Investor Presentation
August 13, 2026
Completion of PALOH-UK Patient Recruitment
August 11, 2026
MT-RNR1 test implemented in the Netherlands
August 4, 2026
New UK clinical guideline for MT-RNR1 testing
August 3, 2026
UK Minister highlights pharmacogenetic testing
July 10, 2026
Board change
July 1, 2026
CYP2C19 Agreement with Thermo Fisher Scientific
June 29, 2026
Manchester NHS Trust transitions MT-RNR1 to BAU
June 18, 2026
Board Changes
May 26, 2026
Sussex NHS Trust transitions MT-RNR1 test to BAU
May 5, 2026
NHS England commercial strategy for MT-RNR1
April 21, 2026
Interactive Investor Hub Updates
April 20, 2026
CYP2C19 kit implemented in North Bristol NHS Trust
April 16, 2026
Interim Results to 31 December 2025
March 30, 2026
Holding(s) in Company
March 12, 2026
Result of General Meeting
March 9, 2026
Publication of circular, notice of GM & timetable
February 19, 2026
Completion of Placing
February 13, 2026
Proposed equity raise of up to £6.0 million
January 19, 2026
Decks in 2026
- Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026